Angel News

Angel News

Back to Homepage

25th March 2020

AstronauTx secures investment from UCL Technology Fund

AstronauTx Ltd, a biotech company developing new medicines designed to restore the normal behaviour of astrocytes for the treatment of Alzheimer’s disease and other neurodegenerative diseases, has received £1 million of investment from the UCL Technology Fund to enable the development of translatable biomarkers for their drug discovery programs.  The UCL Technology Fund is a £53.3million investment fund that is co-managed by UCL Business and AlbionVC that invests in licensing projects and spinout companies arising from the UCL knowledge base.

...

Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:

Name:

Email:

Comment:

Enter the characters in the image shown:



Back to Homepage